Latest News & Features
Asia
Japan’s government officials have warned the UK that the Asian country may reconsider its research and development activities in the UK following Brexit. 8 September 2016
Asia
An increasing number of biologics and biosimilar products are appearing in the Thai market, but there are challenges concerning IP protection and regulation, say Alan Adcock and Atthachai Homhuan of Tilleke & Gibbins. 8 September 2016
Americas
The US District Court for the Southern District of Florida ruled yesterday that Apotex did not infringe Amgen patents centring on its biologic drug Neulasta. 7 September 2016
Americas
Eli Lilly has filed a complaint against Aurobindo Pharma for allegedly infringing a patent covering the drug Cialis. 7 September 2016
Asia-Pacific
More than 2,000 medicine brands treating common conditions will drop in price for millions of Australians from October 1, according to the Australian government’s Department of Health. 6 September 2016
Big Pharma
Pharmaceutical company Alvogen has launched the first generic version of Copaxone in Europe under the name Remurel. 6 September 2016
Europe
Brexit will have significant consequences for the UK regarding SPCs and the unitary patent system, while the UPC’s proposed start date of early 2017 looks highly unlikely, say Christopher Stothers and Paul Abbott of Arnold & Porter. 6 September 2016
Big Pharma
The Francis Crick Institute, Europe’s biggest biomedical research institute, has opened in London. 5 September 2016
Asia
Chugai Pharmaceutical and Fuji Pharma have entered into an agreement to transfer the rights to the manufacture and marketing of cancer drug Vesanoid in Japan. 5 September 2016
Americas
Neos Therapeutics has filed a patent infringement suit against Teva, and its subsidiary Actavis, for allegedly infringing a number of its patents. 2 September 2016